← Leaderboards
Richard J. Wenstrup
Children'S Hospital Med Ctr (Cincinnati)
$2,528,997
Attributed
$2,528,997
Total exposure
9
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $465.6K · FY2005–07$500K$375K$250K$125K$0
'05
'06
'07
Funding mix
By agency
NIH$2,528,997 · 9
By mechanism
R01$2,363,223 · 2
M01$165,774 · 7
Top collaborators
No co-investigators on record.
Most similar at Children'S Hospital Med Ctr (Cincinnati)
Same institution · by research overlap
- Gregory A. Grabowski$10,832,896
- Daniel Joe Lovell$2,028,125
- James E. Heubi$41,505,537
- Lori J Stark$5,093,805
- Heidi J Kalkwarf$6,757,069
Others in their field
Top investigators on “Tissue /Cell Culture”
- James R Gaines · University Of Hawaii At Manoa$24,999,553
- Jay B Jackson · Johns Hopkins University$22,308,100
- C Ronald Kahn · Joslin Diabetes Center$12,500,002
- George Stamatoyannopoulos · University Of Washington$11,744,799
- Laurie H Glimcher · Dana-Farber Cancer Inst$10,563,992
- Peter Karl Sorger · Massachusetts Institute Of Technology$9,821,548
Research focus
Tissue /Cell CultureClinical ResearchCollagenGenetically Modified AnimalsBone DensityFibrogenesisHuman TissueCell Cell InteractionHuman Genetic Material TagFamily GeneticsSkinProtein IsoformsMolecular ChaperonesGenetic Disorder DiagnosisEnzyme TherapyPolymerizationEhlers Danlos SyndromeProtein Structure FunctionCorneaAlendronateOsteogenesis ImperfectaLongitudinal Human StudyHuman Therapy EvaluationMedical Complication
Grant awards (16)
ALENDRONATE DISODIUM IN PEDIATRIC GAUCHER DISEASE$4,458
M01 · FY2007 · RR · contact PI
OSTEOGENESIS IMPERFECTA/IV ZOLEDRONIC ACID VS IV PAMIDRONATE$3,343
M01 · FY2007 · RR · contact PI
OSTEOGENESIS IMPERFECTA/IV ZOLEDRONIC ACID VS IV PAMIDRONATE$33,671
M01 · FY2006 · RR · contact PI
ALENDRONATE DISODIUM IN PEDIATRIC GAUCHER DISEASE$8,271
M01 · FY2006 · RR · contact PI
Use of Hammerhead Ribozymes in Murine Models of Ol$409,823
R01 · FY2005 · AR
OSTEOGENESIS IMPERFECTA/IV ZOLEDRONIC ACID VS IV PAMIDRONATE$45,643
M01 · FY2005 · RR
ALENDRONATE DISODIUM IN PEDIATRIC GAUCHER DISEASE$10,142
M01 · FY2005 · RR
Use of Hammerhead Ribozymes in Murine Models of Ol$398,156
R01 · FY2004 · AR
Alendronate Disodium in Pediatric Gaucher Disease$3,166
M01 · FY2004 · RR
Use of Hammerhead Ribozymes in Murine Models of Ol$408,812
R01 · FY2003 · AR
HUMAN AND MURINE MODELS OF TYPE V COLLAGEN DEFICIENCY$339,304
R01 · FY2003 · AR
HUMAN AND MURINE MODELS OF TYPE V COLLAGEN DEFICIENCY$293,118
R01 · FY2002 · AR
HUMAN AND MURINE MODELS OF TYPE V COLLAGEN DEFICIENCY$296,580
R01 · FY2001 · AR
ANTIRESORPTIVE THERAPY FOR OSTEOPENIA IN GAUCHER DISEASE$28,540
M01 · FY2001 · RR
HUMAN AND MURINE MODELS OF TYPE V COLLAGEN DEFICIENCY$217,430
R01 · FY2000 · AR
ANTIRESORPTIVE THERAPY FOR OSTEOPENIA IN GAUCHER DISEASE$28,540
M01 · FY2000 · RR